Biomedical Engineering Reference
In-Depth Information
150. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K,
Okamura K. Interleukin-10 level in sputum is reduced in bronchial asthma,
COPD and in smokers. Eur Respir J 1999; 14:309-314.
151. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson
IV. An investigation of polymorphism in the interleukin-10 gene promoter.
Eur J Immunogenet 1997; 24:1-8.
152. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga
TW. Interleukin-10 secretion in relation to human IL-10 locus haplotypes.
Proc Natl Acad Sci USA 1998; 95:9465-9470.
153. He J-Q, Connett JE, Anthonisen NR, Par´ PD, Sandford AJ. Gender-specific
association between IL10 polymorphisms and the rate of decline of lung func-
tion in smokers. Am J Hum Genet 2003:S73.
154. Philipson K, Falk R, Camner P. Long-term lung clearance in humans studied
with Teflon particles labeled with chromium-51. Exp Lung Res 1985; 9:31-42.
155. Camner P, Philipson K, Friberg L. Tracheobronchial clearance in twins. Arch
Environ Health 1972; 24:82-87.
156. Davis PB. Autonomic and airway reactivity in obligate heterozygotes for
cystic fibrosis. Am Rev Resp Dis 1984; 129:911-914.
157. Davis PB, Vargo K. Pulmonary abnormalities in obligate heterozygotes for
cystic fibrosis. Thorax 1987; 42:120-125.
158. Poller W, Faber JP,-Scholz S, Olek K, Muller KM. Sequence analysis of the
cystic fibrosis gene in patients with disseminated bronchiectatic lung disease.
Application in the identification of a cystic fibrosis patient with atypical
clinical course. Klin Wochenschr 1991; 69:657-663.
159. Gervais R, Lafitte JJ, Dumur V, Kesteloot M, Lalau G, Houdret N, Roussel
P. Sweat chloride and DF508 mutation in chronic bronchitis or bronchiectasis.
Lancet 1993; 342:997.
160. Dumur V, Lafitte JJ, Gervais R, Debaecker D, Kesteloot M, Lalau G, Roussel
P. Abnormal distribution of cystic fibrosis DF508 allele in adults with chronic
bronchial hypersecretion. Lancet 1990; 335:1340.
161. Pignatti PF, Bombieri C, Benetazzo M, Casartelli A, Trabetti E, Gile LS,
Martinati LC, Boner AL, Luisetti M. CFTR gene variant IVS8-5T in dissemi-
nated bronchiectasis. Am J Hum Genet 1996; 58:889-892.
162. Bombieri C, Benetazzo M, Saccomani A, Belpinati F, Gile LS, Luisetti M,
Pignatti PF. Complete mutational screening of the CFTR gene in 120 patients
with pulmonary disease. Hum Genet 1998; 103:718-722.
163. Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E,
Doudounakis S, Kanavakis E. CFTR gene mutations—including three novel
nucleotide substitutions—and haplotype background in patients with asthma,
disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum
Genet 2001; 108:216-221.
164. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen
M, Droogmans G, Reynaert I, Goossens M, Nilius B, Cassiman JJ. Polyvar-
iant mutant cystic fibrosis transmembrane conductance regulator genes. The
polymorphic (Tg)m locus explains the partial penetrance of the T5
polymorphism as a disease mutation. J Clin Invest 1998; 101:487-496.
